Symetryx Corp

10% OwnerNeuBase Therapeutics, Inc. (NBSE) · full profile →Form 4 · filed Sep 18, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$376K
Net Open-Market Flow
-$376K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2023Sell(S)50K$1.19$60K0
Sep 15, 2023Sell(S)103K$1.26$130K50K
Sep 14, 2023Sell(S)129K$1.44$186K153K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001991925-23-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly: